Higher-dose radiation for early breast cancer in young women
Part of Cancer, Skin clinical trials.
This study tests a higher-dose, faster radiation treatment for young women with early breast cancer who have certain risk factors. The goal is to reduce the chance of cancer coming back while keeping side effects low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a lumpectomy (breast-conserving surgery) for breast cancer.
- You are between 18 and 50 years old.
- You have at least one of these risk factors: lymph node involvement, cancer in blood or lymph vessels, extensive DCIS, close surgical margins, non-hormone-sensitive tumor, or high-grade cancer.
- You have good general health (can do daily activities) and adequate blood counts.
- You are not pregnant or breastfeeding, and have no collagen diseases (like lupus or scleroderma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.